Mass Spectrometry for Drug Discovery and Drug Development. Wiley Series on Mass Spectrometry

  • ID: 3110322
  • Book
  • 476 Pages
  • John Wiley and Sons Ltd
1 of 4

Facilitates the discovery and development of new, effective therapeutics

With coverage of the latest mass spectrometry technology, this book explains how mass spectrometry can be used to enhance almost all phases of drug discovery and drug development, including new and emerging applications. The book′s fifteen chapters have been written by leading pharmaceutical and analytical scientists. Their contributions are based on a thorough review of the current literature as well as their own experience developing new mass spectrometry techniques to improve the ability to discover and develop new and effective therapeutics.

Mass Spectrometry for Drug Discovery and Drug Development begins with an overview of the types of mass spectrometers that facilitate drug discovery and development. Next it covers:

  • HPLC high–resolution mass spectrometry for quantitative assays
  • Mass spectrometry for siRNA
  • Quantitative analysis of peptides
  • Mass spectrometry analysis of biological drugs
  • Applications that support medicinal chemistry investigations
  • Mass spectrometry imaging and profiling

Throughout the book, detailed examples underscore the growing role of mass spectrometry throughout the drug discovery and development process. In addition, images of mass spectra are provided to explain how results are interpreted. Extensive references at the end of each chapter guide readers to the primary literature in the field.

Mass Spectrometry for Drug Discovery and Drug Development is recommended for readers in pharmaceutics, including medicinal chemists, analytical chemists, and drug metabolism scientists. All readers will discover how mass spectrometry can streamline and advance new drug discovery and development efforts.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

Contributors ix

Preface xi

1 Overview of the Various Types of Mass Spectrometers that are Used in Drug Discovery and Drug Development 1Gérard Hopfgartner

2 Utility of High–Resolution Mass Spectrometry for New Drug Discovery Applications 37William Bart Emary and Nanyan Rena Zhang

3 Quantitative Mass Spectrometry Considerations in a Regulated Environment 55Mohammed Jemal and Yuan–Qing Xia

4 Mass Spectrometry for Quantitative In Vitro ADME Assays 97Jun Zhang and Wilson Z. Shou

5 Metabolite Identifi cation Using Mass Spectrometry in Drug Development 115Natalia Penner, Joanna Zgoda–Pols, and Chandra Prakash

6 MS Analysis of Biological Drugs, Proteins, and Peptides 149Yi Du, John Mehl, and Pavlo Pristatsky

7 Characterization of Impurities and Degradation Products in Small Molecule Pharmaceuticals and Biologics 191Hui Wei, Guodong Chen, and Adrienne A. Tymiak

8 Liquid Extraction Surface Analysis (LESA): A New Mass Spectrometry–Based Technique for Ambient Surface Profiling 221Daniel Eikel and Jack D. Henion

9 MS Applications in Support of Medicinal Chemistry Sciences 239Maarten Honing, Benno Ingelse, and Birendra N. Pramanik

10 Imaging Mass Spectrometry of Proteins and Peptides 277Michelle L. Reyzer and Richard M. Caprioli

11 Imaging Mass Spectrometry for Drugs and Metabolites 303Stacey R. Oppenheimer

12 Screening Reactive Metabolites: Role of Liquid Chromatography High–Resolution Mass Spectrometry in Combination with Intelligent Data Mining Tools 339Shuguang Ma and Swapan K. Chowdhury

13 Mass Spectrometry of siRNA 357Mark T. Cancilla and W. Michael Flanagan

14 Mass Spectrometry for Metabolomics 387Petia Shipkova and Michael D. Reily

15 Quantitative Analysis of Peptides with Mass Spectrometry: Selected Reaction Monitoring or High–Resolution Full Scan? 403Lieve Dillen and Filip Cuyckens

Index 427

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

WALTER A. KORFMACHER, PhD, is Director of Bioanalysis at Genzyme, a Sanofi company, and Associate Editor at the Journal of Mass Spectrometry. Previously, he held positions at the FDA′s National Center for Toxicological Research, Schering–Plough Research Institute, Merck Research Laboratories, and Medpace Bioanalytical Laboratories. Dr. Korfmacher is an international leader in developing mass spectrometry techniques and strategies for new drug discovery and drug metabolism applications. A 2009 recipient of the CPSA Distinguished Analytical Scientist Award, he has published more than 150 articles in the scientific literature and made more than eighty presentations at various scientific forums.

Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll